Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RON (Recepteur d'Origine Nantais) is a receptor tyrosine kinase belonging to the MET family. It is activated by its ligand, Hepatocyte Growth Factor-Like protein (HGFL)/Macrophage Stimulating Protein (MSP), leading to downstream signaling through PI3K/AKT, MAPK, Ras, Src, and β-catenin pathways. RON plays a role in cell proliferation, survival, motility, invasion, and inflammation. Overexpression or aberrant activation of RON is implicated in various cancers, making it a potential therapeutic target.
Tyrosine kinase inhibition; Interference with ligand-receptor interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Recepteur d'Origine Nantais Receptor Tyrosine Kinase (RON).